ZIM Labs CPHI Corporate Presentation

1. ZIM ZIM LABORATORIES LIMITED LABORATORIES LIMITED ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 1

2. SAFE HARBOUR SAFE HARBOUR The presentation has been prepared by ZIM Laboratories Limited (“ZIM” or the “Company”) solely for information purposes and does not constitute an offer to sell or recommendation or solicitation of an offer to subscribe for or purchase any securities and nothing contained herein shall form the basis of any contract or commitment whatsoever. By accessing this presentation, you are agreeing to be bound by the trading restrictions. The information contained in this presentation should be considered in the context of the circumstances prevailing at the time and has not been, and will not be, updated to re?ect material developments which may occur after the date of the presentation. The information set out herein may be subject to updating, completion, revision, veri?cation and amendment and such information may change materially. This presentation is based on the economic, regulatory, market and other conditions as in effect on the date hereof. It should be understood that subsequent developments may affect the information contained inthis presentation, which neither the Company nor its affiliates, advisors or representatives are under an obligation to update, revise or affirm. Certain statements contained in this presentation may be statements of the Company’s beliefs, plans and expectations about the future and other forward-looking statements. The forward-looking statements are based on management’s current expectations or beliefs as well as a number of assumptions about the Company’s operations and factors beyond the Company’s control or third-party sources and involve known and unknown risks and uncertaintiesthat could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. Forward looking statements contained in this presentation regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. There is noobligation to update or revise any forward- looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward looking statements, which speak only as of the date of this presentation. The Company, as such, makes no representation or warranty, express or implied, as to, and does not accept any responsibility or liability with respect to, the fairness, accuracy, completeness or correctness of any information or opinions contained herein. You acknowledge and agree that the Company and/or its affiliated companies and/or their respective employees and/or agents have no responsibility or liability (express or implied) whatsoever and howsoever arising (including, without limitation for any claim, proceedings, action, suits, losses, expenses, damages or costs) which may be brought against or suffered by any person as a result of acting in reliance upon the whole or any part of the contents of this presentation and neither the Company, its affiliated companies nor their respective employees or agents accepts any liability for any error, omission or misstatement, negligent or otherwise, in this presentation and any liability in respect of the presentation or any inaccuracy therein or omission therefrom which might otherwise arise is hereby expressly disclaimed. ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 2

3. ZIM : A Brief Introduction ZIM : A Brief Introduction ZIM is a research driven pharmaceutical company that leverages on a range of technology based novel drug delivery solutions and non – infringing proprietary manufacturing processes to develop, manufacture and supply a wide range of innovative and differentiated generic pharmaceutical products Strong R&D expertise in complex generics and NDDS (Novel Drug Delivery Solution) Robust technology platforms capable to manufacture wide range of therapy- agnostic products Consistent and high quality supply of complex drugs Focused on improving patient convenience and adherence of drug treatment EU-GMP approved manufacturing facility ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 3

4. Technology Platforms Technology Platforms StabilityEnhancement Transmucosal Films Casting OralFilms Casting Liquid in Pellets Bi/Multi Layer Film Casting SolventLess Processing SolubilityBioavailabilityEnhancement Taste Masking Active Nano Particulate Granulation MultiLayeredPellets ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 4

5. Strong R&D Capabilities Strong R&D Capabilities Patents under examination - 45 Patents Granted - 9 Solubility Solubility & & Stabilit Enhancement Enhancement Stability y Dosage Dosage Form Form Modi?ed Drug Release Modi?ed Drug Release Dosage Dosage Transformation Transformation Total Total 24 2 4 - 2 14 - 26 28 4 Pellets/Capsules ODS 12 - Tablets 30 12 16 58 Patent Filings Product Registrations -595 Registrations in Pipeline - 436 Dosage Dosage Form Form Registered Registered 396 Applied Applied 210 Pipeline Pipeline 30 Total Total 636 Capsules/Tablets 23 136 40 31 107 48 - 4 6 54 247 94 Suspensions ODS Nutraceuticals ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 5

6. State of the art Manufacturing units State of the art Manufacturing units ORAL ORAL DOSAGE DOSAGE (GENERAL) (GENERAL) ( (EU GMP) EU GMP) ORAL ORAL THIN THIN FILM ORAL THIN FILM FILM (EU GMP) (EU GMP) Manufact Manufactu urin Capabilities Capabilities ring g Tablets, Capsules, DC Granules, Pellets and Dry Syrup EU EU- -GMP, ISO GMP, ISO- -9001 9001 Manufact Manufactu uring Capabilities Capabilities Accreditations Accreditations ring EU EU- -GMP, ISO GMP, ISO- -9001 9001, NSF , NSF- -ANSI 455 ANSI 455- -2 2 Accreditations Accreditations ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 6

7. Oral Solid Dosages Oral Solid Dosages Azithromycin Europe Marketing Authorisations Azithromycin Europe Marketing Authorisations Products with CTD dossier Products with CTD dossier 1. Azithromycin Tablets 250mg/500mg ZIM received marketing authorisations: 2. Azithromycin Oral Suspension 200mg/5ml Germany Germany - Azithromycin ZIM Laboratories 500 mg Filmtabletten 3. Acitretin Capsules 10mg/25mg 4. Dabigatran Etexilate capsules Portugal Portugal – Comprimidos revestidos por película de azitromicina 75mg/110mg/150mg ZIM 500 mg 5. Dimethyl Fumarate DR capsules 120/240 mg 6. Dutasteride and Tamsulosin HCL capsules Poland Poland - Azithromycin ZIM 0.5mg/0.4 mg 7. Mirabegron PR Tablets 25 mg/50 mg 8. Pancreatin capsules 10000 IU/ 25000 IU 9. Tofacitinib Citrate PR tablets 11mg 10. Tofacitinib Citrate tablets 5mg/10mg ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 7

8. Oral Thin Films (OTF): Oral Thin Films (OTF): Thinoral ®, Mucostrip®, Printoral®, Spinoral®, Sublingual, Bi Thinoral ®, Mucostrip®, Printoral®, Spinoral®, Sublingual, Bi - -layer layer Products with CTD Dossier Products with CTD Dossier ZIM’s R&D team has developed Oral Thin Films (OTF) which are manufactured using the company’s in house Patented Thinoral® technology. ZIM manufactures pharmaceuticals and nutraceuticals on Oro dispersible, Sublingual and Buccal thin ?lm technologies. 1. Rizatriptan Benzoate ODS 2. Sildena?l Citrate ODS 3. Ondansetron ODS 4. Tadala?l ODS Recently, ZIM received MAs for 2 of its ODS products: Rizatriptan Benzoate in Portugal and Sildena?l Citrate in Spain 5. Vitamin D3 ODS 6. Melatonin ODS We have 7 patents granted and 14 under examination in OTF 3 12 OTF Pharmaceutical OTF Pharmaceutical Products Developed Products Developed OTF products registered in EU OTF products registered in EU ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 8

9. Nutraceuticals Nutraceuticals Products For Developed Markets Products For Developed Markets 1. Nootropic Extended Release ZIM Labs’ OTF plant is now NSF–ANSI 455-2 accredited for Dietary Supplements 2. Blood Sugar control pellets in capsules ZIM has developed a product basket of Nutraceuticals which complement our pharmaceutical products thus providing a holistic approach to patient health 3. Hangover Support 4. Liver Protectant 5. Anti Aging supplement with Liposomal ZIM is working with differentiated generic active ingredients which are sourced naturally and chemically to create higher efficacy products and product differentiation formulations 6. PMS support for women 7. Caffeine + L-Theanine ODS 8. Liposomal Sleep Aid Capsules 9. Anti – Nausea with Ginger ODS ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 9

10. Partnership model Partnership model Strategic R&D Partner to Global Companies Product Development, Manufacturing & Supply of PFI & Finished dosages Co-Development of New Products Out-Licensing of dossiers and Finished dosages supply Technology Transfer of Manufacturing processes Manufacturing of Complex Generics ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION JUNE 2022 ZIM LABORATORIES LIMITED | CORPORATE PRESENTATION 10

11. THANK YOU